Related Experiment Video
Updated: Oct 5, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
R346K Mutation in the Mu Variant of SARS-CoV-2 Alters the Interactions with Monoclonal Antibodies from Class 2: A
Filip Fratev1,2
1Micar Innovation (Micar21) Ltd., Persenk 34B, 1407 Sofia, Bulgaria.
Abstract:
The Mu variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. In particular, special attention was given to the R346K mutation located in the receptor binding domain (RBD). In the current study, we performed free energy perturbation (FEP) calculations to elucidate its possible impact on a set of neutralizing monoclonal antibodies (mAbs) that have been shown to be strong inhibitors of the most other known COVID-19 variants. Our results show that R346K affects class 2 antibodies but its effect is not so significant (0.66 kcal/mol), i.e., it reduces the binding with antibodies by about 3-fold. An identical value was also calculated in the presence of both class 1 and class 2 antibodies (BD-812/836). Further, a similar reduction in the binding (0.4 kcal/mol) was obtained for the BD-821/771 pair of mAbs. For comparison, the addition of the K417N mutation, present in the newly registered Mu variant in July 2021 in the U.K., affected the class 1 mAbs by strongly reducing the binding by 1.29 kcal/mol or about 10-fold. Thus, the resistance effect of the R346K mutation on the Mu variant is possible but not so significant and is due to the additional decrease of antibody neutralization based on the reduced binding of class 2 antibodies.
Insights
The Mu variant's R346K mutation slightly reduces binding with class 2 neutralizing antibodies, offering limited resistance. This contrasts with the K417N mutation, which significantly impacts antibody binding.
Area of Science:
- Virology
- Immunology
- Computational Biology
Background:
- The SARS-CoV-2 Mu variant (B.1.621 lineage) is a variant of interest (VOI).
- Limited data exists on the Mu variant's impact on neutralizing monoclonal antibodies (mAbs).
- The R346K mutation in the receptor binding domain (RBD) is a key feature of the Mu variant.
Purpose of the Study:
- To investigate the impact of the R346K mutation on the binding affinity of neutralizing monoclonal antibodies (mAbs).
- To compare the effect of R346K with other mutations, such as K417N, found in SARS-CoV-2 variants.
Main Methods:
- Free energy perturbation (FEP) calculations were employed.
- Simulations focused on the interaction between the SARS-CoV-2 RBD and specific neutralizing mAbs.
- Binding affinities were quantified in terms of changes in free energy (kcal/mol).
Main Results:
- The R346K mutation showed a modest reduction in binding affinity (0.66 kcal/mol, ~3-fold) with class 2 antibodies.
- Similar binding reductions were observed for antibody pairs BD-812/836 and BD-821/771.
- In contrast, the K417N mutation significantly reduced binding (1.29 kcal/mol, ~10-fold) with class 1 antibodies.
Conclusions:
- The R346K mutation in the Mu variant confers a degree of resistance to antibody neutralization, primarily by affecting class 2 antibodies.
- The impact of R346K on antibody binding is less significant compared to mutations like K417N.
- Further research is needed to fully understand the neutralization escape mechanisms of the Mu variant.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Single Nucleotide Polymorphisms-SNPs
Viral Mutations
Mutations
Mutations in Microorganisms
Leaky Scanning